LPAR3 Produits
(Lysophosphatidic Acid Receptor 3 (LPAR3))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories LPAR3 en vedette
LPAR3 Anticorps
High quality antibodies with extensive validation data.
LPAR3 Kits ELISA
Reliable ELISA kits for a wide range of species.
LPAR3 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
LPAR3 recommandé Anticorps
- (4)
- (3)
- (2)
LPAR3 recommandé Kits ELISA
- (1)
- (1)
- (1)
LPAR3 recommandé Protéines
- (1)
Dernières publications sur nos produits LPAR3
: "Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI." dans: Biochemical and biophysical research communications, Vol. 491, Issue 3, pp. 587-594, (2017) (PubMed).: "Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model." dans: Journal of the American Society of Nephrology : JASN, Vol. 28, Issue 11, pp. 3300-3311, (2017) (PubMed).
: "LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways." dans: PLoS ONE, Vol. 10, Issue 9, pp. e0139094, (2015) (PubMed).
: "LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs." dans: Molecular and cellular biochemistry, Vol. 408, Issue 1-2, pp. 147-54, (2015) (PubMed).
: "Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells." dans: Molecular carcinogenesis, Vol. 55, Issue 11, pp. 1573-1583, (2015) (PubMed).
: "Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer." dans: Cancer letters, Vol. 192, Issue 2, pp. 161-9, (2003) (PubMed).
: "Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate." dans: Molecular pharmacology, Vol. 57, Issue 4, pp. 753-9, (2000) (PubMed).
: "Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid." dans: Biochemical and biophysical research communications, Vol. 273, Issue 3, pp. 805-10, (2000) (PubMed).
Synonymes et noms alternatifs relatifs à LPAR3
lysophosphatidic acid receptor 3 (LPAR3), lysophosphatidic acid receptor 3 (LOC100038016), lysophosphatidic acid receptor 3 (Lpar3), Edg-7, EDG7, Edg7, GPCR, HOFNH30, LP-A3, LPA3, lpA3, RP4-678I3Protein level used designations for LPAR3
- endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7
- lysophosphatidic acid receptor 3
- LPA receptor 3
- LPA receptor EDG7
- LPA-3
- calcium-mobilizing lysophosphatidic acid receptor LP-A3
- endothelial cell differentiation gene 7
- lysophosphatidic acid receptor Edg-7
- endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 7
- putative G protein-coupled receptor snGPCR32
- snGPCR32